InvestorsHub Logo
Followers 1
Posts 262
Boards Moderated 0
Alias Born 12/13/2009

Re: None

Wednesday, 06/23/2010 6:34:57 AM

Wednesday, June 23, 2010 6:34:57 AM

Post# of 25790
Did anybody read this article posted on the march 9 2010 ?


CSO in Italy is in charge of the last submission !!!

CSO is in Firenze , it's a very nice City ...

If you have a look on the homepage of CSO you have to see what is the latest news !! :)

Seems to me that Italien only care about soccer , women and farniente.... but always be carefull with what they telling you ...

Italien will be WSC champion ! GO PDMI


The FDA decision on Paradigm Medical Industries, Inc. (OTC: PDMI) lead device candidate ParaMax for Glaucoma early detection is expecting anytime soon.
ParaMax device for early Glaucoma detection is awaiting FDA approval.
Paradigm’s (OTC: PDMI) has recently announced that his Italian partner CSO (Costruzione Strumenti Oftalmici) has completed and submitted all necessary documents to the FDA regarding his lead device candidate ParaMax for Glaucoma early detection.
Paradigm team has been very busy these last months, preparing the release of fantastic new devices.
Paradigm is still in talk with different financial partners but now it seems they are being very selective in selecting the right one that will benefit the company the most.
Paradigm has many products to address the optometrist market but we will focus here on the 3 new products with the biggest potential.....

www.themarketfinancial.com/fda-decision-expected-soon-for-paramax-paradigm-medical-otcpdmi-2/1850